Clin2
NCT07429253Possibly a fitRecruiting

Secretome vs. PRP for male and female hair loss

Androgenetic Alopecia

Treatments studied

Part of Skin clinical trials.

This trial compares two treatments—secretome and platelet-rich plasma (PRP)—to see which helps grow thicker, denser hair in people with genetic hair loss (androgenetic alopecia). It's for adults aged 25 to 59 who have stopped taking certain hair loss medications for at least a month.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
40 people
Ages
25 years to 59 years
Study type
Interventional

Who can take part

  • You are 25 to 59 years old.
  • You have male or female pattern hair loss (diagnosed by a doctor).
  • You have not used minoxidil or anti-androgen medications for at least 1 month.
  • You are not pregnant or breastfeeding (if female).
  • You have no active scalp infections, dermatitis, or known allergies to the treatments.
  • You can understand Indonesian and agree to be in the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07739147Not yet recruiting· Early Phase 1
Platelet-rich plasma for hair loss: comparing two treatments

This trial compares two types of platelet-rich plasma (PRP) treatments for people with pattern hair loss. PRP uses your own blood to help stimulate hair growth. The study will see if using a special light with PRP works better than standard PRP.

NCT06826001Not yet recruiting· Phase 2
Procedural treatments for male pattern hair loss

This trial compares different in-office procedures (like injections, lasers, or platelet-rich plasma) to treat male pattern hair loss. It aims to find which method works best to help hair grow back or stop thinning. Participation could provide access to new treatments that target the root cause of hair loss.

Rahim Yar Khan, Punjab Province
NCT07618195Recruiting· Phase 1/Phase 2
Testing EPI-001 for male and female pattern hair loss

This study tests an experimental treatment called EPI-001 for androgenetic alopecia—the most common type of hair loss affecting men and women. Researchers will measure how well it works by tracking hair growth over time using special photography and scalp analysis.

Seoul, Seoul
NCT07112586Not yet recruiting· Phase 1/Phase 2
Exosome injections for common male hair loss

This trial tests whether injecting exosomes, tiny particles from cells, into the scalp can help regrow hair in men with common male pattern baldness. It's an early-stage study that also looks at how the treatment affects hair follicles.

Cairo, Abbasia
NCT07758400Not yet recruiting
Microneedling for male pattern hair loss

This study tests whether microneedling (a procedure using tiny needles on the scalp) can safely help regrow hair in men with male pattern baldness. Participants will receive the procedure and be monitored over time with scalp photos.

Beijing, Beijing Municipality
NCT07248410Not yet recruiting
Laser treatment with and without exosomes for male hair loss

This trial tests whether adding exosomes (tiny cell-repair particles) to a fractional laser treatment helps regrow hair more effectively than laser alone in men with common pattern baldness. If you qualify, you'll receive treatment on part of your scalp while doctors compare both approaches.

Taoyuan, Taoyuan

Hear when a new Androgenetic Alopecia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.